Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society's recommendations for best clinical practice.

Eldabe, S.; Duarte, R.; Thomson, S.; Bojanic, S.; Farquhar-Smith, P.; Bagchi, S.; Farquhar, L.; Wetherill, B.; Copley, S.

Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society's recommendations for best clinical practice.

All Authors

Eldabe, S.

Duarte, R.

Thomson, S.

Bojanic, S.

Farquhar-Smith, P.

Bagchi, S.

Farquhar, L.

Wetherill, B.

Copley, S.

LTHT Author

Farquhar, Lis

LTHT Department

Medicines Management & Pharmacy Services
Pain Management

Non Medic

Pharmacist

Publication Date

2024

Item Type

Journal Article

Abstract

The British Pain Society updated their recommendations on intrathecal drug delivery (ITDD) for the management of pain and spasticity in adults. The recommendations are primarily evidence based but where necessary comprise the consensus opinion of the working group. The recommendations are accompanied by information for patients and their carers, intended to inform and support patients in their decision making. The updated guidance includes recent evidence base of ITDD use in pain and spasticity, address the issues of drug pump compatibility following the latest manufacturer and Medicines and Healthcare products Regulatory Agency (MHRA) recommendations as well as provide an update on the indications and complication management particularly endocrine complications and intrathecal granuloma formation.